Zobrazeno 1 - 10
of 49
pro vyhledávání: '"M. Gawkowska-Suwinska"'
Autor:
Rafał Suwiński, Anna Drosik, Agata Kosarewicz, M. Gawkowska-Suwinska, Barbara Masłyk, Agnieszka Gdowicz-Kłosok, Dorota Butkiewicz, Marek Rusin, Małgorzata Krześniak, Monika Giglok
Publikováno v:
International Journal of Cancer. 137:2332-2342
Certain common inherited variations in genes involved in tumor angiogenesis, progression and metastasis may contribute to cancer therapy outcome and prognosis by altering the gene expression and protein activity. In this report, we examined the effec
Autor:
A. Zajusz, M. Gawkowska-Suwinska, Elżbieta Nowicka, Łukasz Zarudzki, Beata Smolska-Ciszewska, Rafal Tarnawski, Łukasz Boguszewicz, A. Heyda, Katarzyna Behrendt, Sławomir Blamek, Anna Cichoń, G. Plewicki
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 19:361-368
AimTo evaluate the tolerability and toxicity of PCI in patients with NSCLC.BackgroundProphylactic cranial irradiation (PCI) is a standard treatment for patients with small cell lung cancer. There are data showing a decreasing ratio of brain metastase
Autor:
Elżbieta Nowicka, M. Gawkowska-Suwinska, Monika Giglok, Beata Smolska-Ciszewska, G. Plewicki, A. Zajusz, Katarzyna Behrendt, Rafał Suwiński
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 19:337-342
AimTo assess acute and late toxicity of hypofractionated radiotherapy, its efficacy and impact on quality of life in patients with low-risk prostate cancer.Materials and methodsSince August 2006 to October 2007, 15 prostate cancer patients with favor
Autor:
Katarzyna Behrendt, A. Zajusz, Elżbieta Nowicka, Agnieszka Gogler, Ewa Malusecka, Beata Smolska, M. Gawkowska-Suwinska
Publikováno v:
The Open Prostate Cancer Journal. 3:74-77
Autor:
Grzegorz Głowacki, Marta Szlag, M. Gawkowska-Suwinska, Agnieszka Cholewka, Sylwia Kellas-Ślęczka, Marek Fijałkowski, Brygida Białas, Piotr Wojcieszek
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 119(3)
Background and purpose To evaluate high-dose-rate brachytherapy (HDR BT) as a salvage modality for locally recurrent prostate cancer after primary radiotherapy failure. Materials and methods Eighty-three prostate cancer patients, who locally relapsed
Autor:
Beata Smolska-Ciszewska, Brygida Białas, M. Gawkowska-Suwinska, Leszek Miszczyk, Monika Giglok, Katarzyna Behrendt, A. Zajusz, G. Plewicki, Rafał Suwiński, Marek Fijałkowski, Elżbieta Nowicka
Publikováno v:
Radiation Oncology (London, England)
Background Clinical data that compare external-beam radiotherapy (EBRT) combined with high-dose-rate brachytherapy (HDR-BT) boost versus EBRT alone are scarce. The analysis of published studies suggest that biochemical relapse-free survival in combin
Autor:
Rafal Tarnawski, W. Bal, M. Gawkowska-Suwinska, H. Grzbiela, E. Nowicka, M. Jarząb, Barbara Bobek-Billewicz
Publikováno v:
Radiotherapy and Oncology. 119:S540-S541
Autor:
Brygida Białas, Tomasz Dworzecki, Rafał Suwiński, Katarzyna Behrendt, M. Gawkowska-Suwinska, Philip S. Boonstra, Beata Smolska-Ciszewska, Jeremy M. G. Taylor
Publikováno v:
The British Journal of Radiology. 89:20150957
There is disagreement regarding the value of the α/β ratio for prostate cancer. Androgen deprivation therapy (ADT) may dominate the effects of dose fractionation on prostate-specific antigen (PSA) response and confound estimates of the α/β ratio.
Autor:
Marek Rusin, Agata Kosarewicz, Małgorzata Krześniak, Anna Drosik, M. Gawkowska-Suwinska, Dorota Butkiewicz, Iwona Matuszczyk, Jadwiga Rachtan, Rafał Suwiński
Publikováno v:
International journal of cancer. 131(7)
Polymorphisms in DNA repair genes may modulate not only an individual DNA repair capacity, DNA damage levels and cancer risk but also clinical outcome after DNA damage-inducing anticancer therapy. In this study, we analyzed the association between th
Autor:
Elzbieta Gubala, Barbara Jarzab, Józef Roskosz, Jolanta Krajewska, Michal Jarzab, Zbigniew Puch, Ewa Paliczka-Cieslik, Aleksandra Kukulska, Daria Handkiewicz-Junak, M. Gawkowska-Suwinska
Publikováno v:
Thyroid Research, Vol 3, Iss 1, p 9 (2010)
Thyroid Research
Thyroid Research
Background The aim of this study is to compare the effectiveness of 131I therapy between three groups of DTC patients who received 30, 60 or 100 mCi for thyroid remnant ablation after total thyroidectomy and were postoperatively judged with low risk